Value Microcaps Motherboard

[cliffvb]

What I don't like about VPHM is that they are capitalizing their acquisition costs for Vancocin over a 25 year period. There is no real competition to the drug now but as demand continues to grow for it, I can't imagine that competition won't be a factor within much less than 25 years. Also there is no longer any patent protection on Vancocin. They are looking for other products but for now anyway this is basically a one-show pony in terms of revs and profits. It was a great ride up last year....good luck with this one going forward.